All articles tagged with #gene editing
Originally Published 18 hours ago — by WIRED
Jennifer Doudna's startup Aurora Therapeutics aims to scale personalized gene-editing treatments for rare diseases like PKU using CRISPR technology and a new FDA pathway that expedites approval for bespoke therapies based on limited patient data.
Originally Published 2 days ago — by statnews.com
A prominent gene editing researcher from UC Berkeley, Fyodor Urnov, and venture capitalist Johnny Hu are launching a startup to scale personalized CRISPR medicines, aiming to treat ultra-rare genetic mutations and overcome regulatory and commercial challenges.
Originally Published 6 days ago — by SciTechDaily
Scientists at the University of Kentucky developed a mouse model that can switch the APOE gene from a high-risk to a protective form in adults, leading to improvements in Alzheimer’s disease markers and cognitive function, highlighting potential gene-based therapies for the future.
Originally Published 10 days ago — by Nature
The article discusses upcoming scientific developments in 2026, including advancements in AI, human gene editing, space missions, and the impact of US policy changes on science, highlighting key events to watch for this year.
Originally Published 11 days ago — by statnews.com
Despite political challenges, 2025 saw significant medical advances including a groundbreaking gene edit for a baby, approval of 44 new drugs, progress in cancer treatments, improved vaccines, and innovative biotech research, highlighting biology's pivotal role in this century of medicine.
Originally Published 12 days ago — by ABC News
2025 has seen major medical breakthroughs including remote robotic surgery, a blood test for Alzheimer's, brain implants for ALS, advances in organ transplants, and gene editing treatments, transforming healthcare and patient outcomes.
Originally Published 13 days ago — by Endpoints News
The article discusses the ongoing development of gene editing technologies, highlighting the excitement and competition among scientists to discover the most effective and final form of gene editing tools.
Originally Published 15 days ago — by BBC
India's first gene-edited sheep, Tarmeem, has turned one year old and is thriving, showing increased muscle growth due to CRISPR technology targeting the myostatin gene. Researchers aim to use this technology to enhance meat production sustainably in Kashmir, potentially revolutionizing local agriculture and addressing food security issues. The project marks a significant step in applying gene editing in livestock within India, though regulatory and ethical considerations remain.
Originally Published 16 days ago — by The Guardian
A leading surgeon, Dr. Robert Montgomery, discusses the potential of pig organ transplants, which have been gene-edited to reduce rejection, as a promising solution to the organ shortage crisis, with initial trials showing positive results and the possibility of future improvements making pig organs potentially superior to human ones.
Originally Published 24 days ago — by Nature
2026 is set to be a significant year for science with advancements in AI, clinical trials for gene therapies, a major cancer detection trial in the UK, increased lunar exploration including NASA's Artemis II and China's Chang’e-7, and space missions targeting Mars, the Moon, and exoplanets, alongside new ocean drilling initiatives in China.
Originally Published 25 days ago — by Nature
In 2025, despite political challenges in the US, positive scientific developments included the recovery of endangered species, shrinking of the Antarctic ozone hole, breakthroughs in gene therapy for diseases like Huntington's, and a significant boost in renewable energy adoption, notably in China, marking hopeful progress in environmental and medical sciences.
Originally Published 2 months ago — by Investor's Business Daily
Crispr and Intellia stocks surged following promising updates on their gene-editing therapies, with Crispr showing potential for a one-time cholesterol treatment and Intellia demonstrating a near-cure for hereditary angioedema, leading to significant stock gains despite recent setbacks in the sector.
Originally Published 2 months ago — by The Washington Post
A small group with high cholesterol experienced significant risk reduction after a single high-dose gene-editing treatment, offering a potential new approach to lowering heart disease risk.
Originally Published 2 months ago — by statnews.com
A preliminary study using CRISPR gene editing therapy showed significant reductions in 'bad' cholesterol and triglycerides in patients with heart disease, suggesting potential for one-time treatments to prevent heart attacks, though concerns about safety and ethical considerations remain.
Originally Published 2 months ago — by NPR
A small study suggests that a single infusion of a CRISPR-based gene-editing drug can safely reduce cholesterol and triglycerides by about half, potentially offering a one-time cure for high cholesterol, though more research is needed to confirm safety and long-term effects.